StockData
Turn Therapeutics Inc. logo

Turn Therapeutics Inc. (TTRX) income statement

TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30
$8.10−0.54 (-6.31%)

Close on Nov 20, 2026Market cap $241.13MP/E –Yield –

See a number that looks wrong?